A detailed history of Rise Advisors, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Rise Advisors, LLC holds 212 shares of JAZZ stock, worth $26,031. This represents 0.01% of its overall portfolio holdings.

Number of Shares
212
Previous 212 -0.0%
Holding current value
$26,031
Previous $22,000 4.55%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

BUY
$115.19 - $132.77 $23,383 - $26,952
203 Added 2255.56%
212 $25,000
Q4 2021

Feb 24, 2022

BUY
$119.87 - $145.67 $1,078 - $1,311
9 New
9 $1.15 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.